Barrett's esophagus: Update of pathophysiology and management

Hepato-Gastroenterology

Volumn 45, Issue 23, 1998, Pages 1348-1356

  Oberg, Stefan ^a   Clark, Geoffrey W B ^a   DeMeester, Tom R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; ARTICLE; BARRETT ESOPHAGUS; DUODENUM FLUID; DYSPLASIA; EARLY CANCER; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEALING; HUMAN; INTESTINE METAPLASIA; PRECANCER; PRIORITY JOURNAL; SYMPTOM;

BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; HUMANS;

EID: 0031736804     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (91)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF, Jr: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:1287-9.
2. Hesketh PJ, Clapp RW, Doos WG, Spechler SJ: The increasing frequency of adenocarcinoma of the esophagus. Cancer 1989; 64(2):526-30.
3. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG: Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96:1249-56.
4. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ: An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993; 105:40-50.
5. Spechler SJ, Goyal RK: Barrett's esophagus. N Engl J Med 1986; 315:362-71.
6. Cooper BT, Barbezat GO: Barrett's oesophagus: a clinical study of 52 patients. Q J Med 1987; 62(238):97-108.
7. Winters C, Jr., Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF3, Johnson DA, Cruess DF, Cotelingam JD, Gurney MS: Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92:118-24.
8. Mann NS, Tsai MF, Nair PK: Barrett's esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterol 1989; 84(12):1494-6.
9. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA: Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99:918-22.
10. Iascone C, DeMeester TR, Little AG, Skinner DB: Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg 1983; 118(5):543-9.
11. Parrilla P, Ortiz A, Martinez de Haro LF, Aguayo JL, Ramirez P: Evaluation of the magnitude of gastrooesophageal reflux in Barrett's oesophagus. Gut 1990; 31:964-7.
12. Gillen P, Keeling P, Byrne PJ, Hennessy TP: Barrett's oesophagus: pH profile. Br J Surg 1987; 74(9):774-6.
13. Attwood SE, DeMeester TR, Bremner CG, Barlow AP, Hinder RA: Alkaline gastroesophageal reflux: Implications in the development of complications in Barrett's columnarlined lower esophagus. Surgery 1989; 106:764-70.
14. Stein HJ, Barlow AP, DeMeester TR, Hinder RA: Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 1992; 216:35-43.
15. Stein HJ, Hoeft S, DeMeester TR: Functional foregut abnormalities in Barrett's esophagus. J Thorac Cardiovasc Surg 1993; 105:107-11.
16. DeMeester TR, Attwood SE, Smyrk TC, Therkildsen DH, Hinder RA: Surgical therapy in Barrett's esophagus. Ann Surg 1990; 212:528-40; discussion 540-2.
17. Mason RJ, Bremner CC: Motility differences between long-segment and short-segment Barrett's esophagus. Am J Surg 1993; 165:686-9.
18. Lillemoe KD, Gadacz TR, Harmon JW: Bile absorption occurs during disruption of the esophageal mucosal barrier. J Surg Res 1983; 35(1):57-62.
19. Schweitzer EJ, Harmon JW, Bass BL, Batzri S: Bile acid efflux precedes mucosal barrier disruption in the rabbit esophagus. Am J Physiol 1984; 247(5 Pt 1):G480-5.
20. Haggit RC, Tryzelaar J, Ellis FH, Colcher H: Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am Soc Cl Pathol 1978; 70:1-5.
21. Thompson JJ, Zinsser KR, Enterline HT: Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum Pathol 1983; 14:42-61.
22. Salo JA, Lehto VP, Kivilaakso E: Morphological alterations in experimental esophagitis. Light microscopic and scanning and transmission electron microscopic study. Dig Dis Sci 1983; 28(5):440-8.
23. Shimono M, Clementi F: Intercellular junction of oral epithelium. J Ultrastruct Res 1977; 59:101-12.
24. Batzri S, Harmon JW, Schweitzer EJ, Toles R: Bile acid accumulation in gastric mucosal cells. Proc Soc Exp Biol Med 1991; 197(4):393-9.
25. Schweitzer EJ, Bass BL, Batzri S, Harmon JW: Bile acid accumulation by rabbit esophageal mucosa. Dig Dis Sci 1986; 31(10):1105-13.
26. Schweitzer EJ, Bass BL, Batzri S, Young PM, Huesken J, Harmon JW: Lipid solubilization during bile salt-induced esophageal mucosal barrier disruption in the rabbit. J Lab Clin Med 1987; 110(2):172-9.
27. Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA: Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995; 222:525-31; discussion 531-3.
28. Fried M, Siegrist H, Frei R, Froehlich F, Duroux P, Thorens J, Blum A, Bille J, Gonvers JJ, Gyr K: Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 1994; 35:23-6.
29. Thorens J, Froehlich F, Schwizer W, Saraga E, Bille J, Gyr K, Duroux P, Nicolet M, Pignnatelli B, Blum A, et al: Bacterial overgroth during treatment with omeprazole compared with cimetidine: A prospective randomised double blind study. Gut 1996; 39:54-8.
30. Kermeli Y, Stalnikowitz R, Eliakim R, Rahav G: Conventional dose of Omeprazole alters gastric flora. Dig Dis Sci 1995; 40:2070-3.
31. Domellof L, Reddy BS, Weisburger JH: Microflora and deconjugation of bile acids in alkaline reflux after partial gastrectomy. Am J Surg 1980; 140:291-5.
32. Lillemoe KD, Johnson LF, Harmon JW: Role of the components of the gastroduodenal contents in experimental acid esophagitis. Surgery 1982; 92(2):276-84.
33. Salo J, Kivilaakso E: Contribution of trypsin and cholate to the pathogenesis of experimental alkaline reflux esophagitis. Scand J Gastroenterol 1984; 19:875-81.
34. Meyer M, Vollmar F, Bar W: Barrett-esophagus following total gastrectomy. Endoscopy 1979; 2:121-6.
35. Morrow D, Passaro Er: Alkaline reflux esophagitis after total gastrectomy. Am J Surg 1976; 132:287-91.
36. Attwood SE, Smyrk TC, DeMeester TR, Mirvish SS, Stein HJ, Hinder RA: Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 1992; 111:503-10.
37. Clark GW, Smyrk TC, Mirvish SS, Anselmino M, Yamashita Y, Hinder RA, DeMeester TR, Birt DF: Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol 1994; 1(3):252-61.
38. Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, DeMeester TR: Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983; 198:554-65.
39. Schnell TG, Sontag SJ, Chejfec G: Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992; 37:137-43.
40. Clark GW, Smyrk TC, Hoeft SF: Is the length of Barrett's mucosa related to prevalence of complications and adenocarcinoma in Barrett's esophagus. Gastroenterology 1993; 104:393
41. Spechler SJ, Robbing AH, Rubins HB, Vincent ME, Heeren T, Doos WG, Colton T, Schimmel EM: Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984; 87:927-33.
42. Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, Hinder RA, Bremner CG, DeMeester TR: Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994; 129:609-14.
43. Clark GW, Ireland AP, Chandrasoma P, et al: Inflammation and metaplasia in the transitional epithelium of the gastroesophageal junction: A new marker for gastroesophageal reflux disease. Gastroenterology 1994; 106:A63
44. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK: Prevalence of metaplasia at the gastrooesophageal junction. Lancet 1994; 344:1533-6.
45. Lee RG: Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients. Am J Surg Pathol 1985; 9(12):845-52.
46. Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC: Barrett's esophagus with high-grade dysplasia: An indication for esophagectomy? Ann Thorac Surg 1992; 54(2):199-204.
47. Altorki NK, Sunagawa M, Little AG, Skinner DB: High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991; 161:97-9; discussion 99-100.
48. Rice TW, Falk GW, Achkar E, Petras RE: Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993; 88(11):1832-6.
49. McArdle JE, Lewin KJ, Randall G, Weinstein W: Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum Pathol 1992; 23:479-82.
50. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggit RC, Ahren C, Correa P, Hamilton SR, Morson BC, et al: Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Human Pathology 1983; 14(11):931-68.
51. Schmidt HG, Riddell RH, Walther B, Skinner DB, Riemann JF: Dysplasia in Barrett's esophagus. J Cancer Res Clin Oncol 1985; 110(2):145-52.
52. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H: Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988; 19:166-78.
53. Geisinger KR, Teot LA, Richter JE: A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus. Cancer 1992; 69(1):8-16.
54. Sprung DJ, Ellis FH, Cibb S: Incidence of adenocarcinoma in Barrett's esophagus. Gastroenterology 1984; 79:-817
55. Cameron AJ, Ott BJ, Payne WS: The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313(14):857-9.
56. Kobertson CS, Mayberry JF, Nieholson DA, James PD, Atkinson M: Value of endoscopie surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988; 75:760-3.
57. Van der Veen AH, Dees J, Blankensteijn JD, Van Blankenstein M: Adenocarcinoma in Barrett's oesophagus: An overrated risk. Gut 1989; 30(1):14-8.
58. Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M: Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992; 33(9):1155-8.
59. Hamilton SR, Smith RR, Cameron JL: Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988; 19(8):942-8.
60. Ransom JM, Patel GK, Clift SA, Womble NE, Read RC: Extended and limited types of Barrett's esophagus in the adult. Ann Thorac Surg 1982; 33(1):19-27.
61. Williamson WA, Eills FH, Jr., Gibb SP, Shahian DM, Aretz HT, Heatley GJ, Watkins E, Jr: Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991; 151:2212-6.
62. Clark GW, Ireland AP, Peters JH, Chandrasoma P, DeMeester TR, Bremner CG: Short-Segment Barrett's Esophagus: A Prevalent complication of Gastroesophageal Reflux Disease With Malignant Potential. J Gastrointestinal Surg 1997; 1:113-22.
63. Cameron AJ: Barrett's esophagus and adenocarcinoma: From the family to the gene. Gastroenterology 1992; 102:1421-4.
64. Streitz JM, Jr., Andrews CW, Jr., Ellis FH, Jr: Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg 1993; 105(3):383-7;discussion 387-8.
65. Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR: Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108:813-21; discussion 821-2.
66. Heitmiller RF, Redmond M, Hamilton SR: Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996; 224:66-71.
67. Li H, Walsh TN, Hennessy TP: Carcinoma arising in Barrett's esophagus. Surg Gynecol Obstet 1992; 175(2):167-72.
68. Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, LeSaffre E: Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992; 216(5):583-90.
69. Clark GW, Dreuw B, Burdiles P: The importance of endoscopic surviellance in the detection of early Barrett's adenocarcinoma. Gastroenterology 1993; 104:392
70. Reid BJ, Weinstein WM, Lewin KJ, Haggitt RC, VanDeventer G, DenBesten L, Rubin CE: Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988; 94:81-90.
71. Spechler SJ: Columnar metaplasia of the esophagus (Barrett's epithelium). In Eastwood GL, Ed. Premalignant conditions of the gastrointestinal tract. New York Elseviewer 1991; 123-43.
72. DeMeester TR, Bonavina L, Albertucci M: Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg 1986; 204(1):9-20.
73. Spechler SJ: Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The department of veterans affairs gastroesophageal reflux disease study group. N Engl J of Med 1992; 326:786-92.
74. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, Mitchell B, Beveridge BR, Laurence BH, Gibson GG: Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95(4):903-12.
75. Klinkenberg Knol EC, Jansen JM, Festen HP, Meuwissen SG, Lamers CB: Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; 1(8529):349-51.
76. Ladas SD, Tassios PS, Raptis SA: Criteria for alternate day omeprazole maintenance therapy in patients with grade 2-3 reflux esophagitis. Gastroenterology 1997; 112:(4)A189
77. Ippoliti AF, Weinstein WM, Lieberman DA, et al: Resistance to high dose anti-secretory drugs in Barrett's esophagus. Gastroenterology 1997; 112:A583
78. Pehghini P, Katz P, Bedassy A, et al: Nocturnal acid breakthrough during twice daily (bid) administration of proton pump inhibitor (PPI). Gastroenterology 1997; 112:A255
79. Katzka DA, Castell DO: Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1994; 89(7):989-91.
80. Naef AP, Savary M, Ozzello L: Columnar lined lower esophagus: An acquired lesion with malignant predisposition. J Thorac Cardiovasc Surg 1975; 70(5):826-34.
81. Ollyo JB, Monnier P, Savary M: The natural history, prevalence and incidence of reflux oesophagitis. Gullet 1993; 3:3-10.
82. Levine MS, Caroline D, Thompson JJ, Kressel HY, Laufer I, Herlinger H: Adenocarcinoma of the esophagus: relationship to Barrett mucosa. Radiology 1984; 150(2):305-9.
83. Haggitt RC, Tryzelaar J, Ellis FH: Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. J Clin Pathol 1979; 70:1-5.
84. Streitz JM, Jr., Williamson WA, Ellis FH, Jr: Current concepts concerning the nature and treatment of Barrett's esophagus and its complications. Ann Thorac Surg 1992; 54(3):586-91.
85. McDonald M, Trastek V, Allen M, Deschamps C, Pairolero P: Barrett's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance? J Thoracic and Cardiovasc Surgery 1996; 111(6):1135-1140
86. McCallum RW, Polepalle S, Davenport K, Frierson H, Boyd S: Role of antireflux surgery against dysplasia in Barretts esophagus. Gastroenterology 1991; 100:A121
87. Cameron AJ, Carpenter HC, Trastek VF: Barrett's esophagus with high grade dysplasia: Is resection required? Gastroenterology 1997; 106:375
88. Spechler SJ, Goyal RK: Cancer surveillance in Barrett's esophagus: what is the end point? Gastroenterology 1994; 106(1):275-7.
89. Clark GW, Ireland AP, DeMeester TR: Dysplastic Barrett's: Is continued surveillance appropriate? Gastroenterology 1994; 106(4):1128.
90. Hamilton SR, Smith RR: The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987; 87(3):301-12.
91. Altorki NK, Skinner DB, Segalin A, Stephens JK, Ferguson MK, Little AG: Indications for esophagectomy in nonmalignant Barrett's esophagus: A 10-year experience. Ann Thorac Surg 1990; 49(5):724-6.